Concepedia

Scott Turner

ST

Statistics

Publications

6

Citations

443

H-Index

6

Active since

2012

Affiliations

Gilead Sciences (United States)(Current)

Hôpital Beaujon

Chinese University of Hong Kong

Scott Turner is an author at Gilead Sciences (United States) specializing in medicine, viral hepatitis, and liver disease.

ORCID

Publications per year

2012–2022

6

Publications

6

Bevacizumab therapy for adults with recurrent/progressive meningioma: a retrospective series

Emil Lou, Ashley Sumrall, Scott Turner et al. · Journal of Neuro-Oncology · 2012 · 195 citations · Full text

, , +7

Multi-parametric analysis of human livers reveals variation in intrahepatic inflammation across phases of chronic hepatitis B infection

Noe Rico Montanari, Ricardo Ramírez, Abhishek Aggarwal et al. · Journal of Hepatology · 2022 · 80 citations · Full text

, , +14

Characterization of the liver immune microenvironment in liver biopsies from patients with chronic HBV infection

Nicholas van Buuren, Ricardo Ramírez, Scott Turner et al. · JHEP Reports · 2021 · 51 citations · Full text

, , +17

Targeted long-read sequencing reveals clonally expanded HBV-associated chromosomal translocations in patients with chronic hepatitis B

Nicholas van Buuren, Ricardo Ramírez, Cameron M. Soulette et al. · JHEP Reports · 2022 · 49 citations · Full text

, , +17

Randomized, open-label, phase 2 study of andecaliximab plus nivolumab versus nivolumab alone in advanced gastric cancer identifies biomarkers associated with survival

Manish A. Shah, David Cunningham, Jean‐Philippe Metges et al. · Journal for ImmunoTherapy of Cancer · 2021 · 43 citations · Full text

, , +17

1–5 of 6